Eurofins Scientific SE provided revenue guidance for the fiscal year 2024. For the year, the company expects revenue including M&A of 7,250 million.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
55.04 EUR | +0.44% | -0.58% | -6.68% |
05-31 | EUROFINS SCIENTIFIC : EPS cut (2023: -28.6%, 2024: -18.4%) | |
05-13 | Eurofins Scientific to Expand US Battery Materials Testing Capabilities | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.68% | 11.5B | |
+23.83% | 88.22B | |
-22.49% | 76.5B | |
+1.76% | 26.97B | |
+7.98% | 18.61B | |
-12.53% | 16.72B | |
+3.83% | 15.85B | |
+74.11% | 13.41B | |
+78.07% | 13.16B | |
+23.79% | 12.67B |
- Stock Market
- Equities
- ERF Stock
- News Eurofins Scientific SE
- Eurofins Scientific SE Provides Revenue Guidance for the Fiscal Year 2024